Tranexamic acid (TXA) can be given intravenously, orally, topically, or by nebulizer, depending on the clinical situation. The route and dose vary widely: a trauma patient in an emergency department receives it through an IV drip, while someone managing heavy periods takes it as a tablet at home. Here’s how each method works and when it’s used.
How TXA Works
TXA is a synthetic compound that helps blood clots stay intact. Normally, your body forms clots to stop bleeding, then gradually breaks them down through a process called fibrinolysis. TXA slows that breakdown by blocking key binding sites on the proteins responsible for dissolving clots. The result is that clots hold together longer, which reduces bleeding. It’s roughly six to ten times more potent than its older cousin, aminocaproic acid, making it the preferred option in most settings today.
Intravenous Administration
IV delivery is the most common route in emergencies and during surgery. The standard protocol, established by the landmark CRASH-2 trial, calls for a 1-gram loading dose mixed into 100 mL of normal saline and infused over 10 minutes. A second 1-gram dose is then infused slowly over the following 8 hours. The total should not exceed 2 grams in 24 hours.
Speed matters. Pushing TXA too fast through an IV can cause a sudden drop in blood pressure. That’s why guidelines specify a slow infusion rather than a rapid push. When diluted, the solution is typically delivered at about 5 mL per minute for a 1% concentration (1 gram in 100 mL).
TXA can be mixed with normal saline, 5% glucose solution, Ringer’s solution, or dextran fluids. It should never be mixed with blood products or solutions containing penicillin.
The 3-Hour Window in Trauma
In trauma patients with significant bleeding, TXA is most effective when given within 3 hours of injury. Both the CRASH-2 and CRASH-3 trials showed reduced 28-day mortality when TXA was administered inside this window, including in patients with traumatic brain injuries. After 3 hours, the benefit drops off, which is why paramedics in many systems now carry TXA and administer it before the patient reaches the hospital.
Oral Tablets
For heavy menstrual bleeding, TXA comes as 650-milligram tablets sold under the brand name Lysteda. The standard dose is two tablets (1,300 mg total) taken three times a day: morning, afternoon, and evening. You take them only during the days of heavy bleeding, and no more than 5 consecutive days per menstrual cycle. This approach can reduce menstrual blood loss significantly without hormonal side effects.
Topical Application
Surgeons increasingly apply TXA directly to wound surfaces to reduce bleeding without systemic absorption. The methods vary by procedure but generally fall into a few categories:
- Wound moistening: A diluted solution (typically 25 mg/mL) is applied as a thin film over a surgical wound surface, used in procedures like breast surgery.
- Soaked gauze: Gauze soaked in a 20 mg/mL solution is pressed against the bleeding surface for about 5 minutes, a technique used in procedures to remove uterine fibroids.
- Direct irrigation: A higher concentration (up to 100 mg/mL undiluted) is poured or irrigated directly into a wound bed or surgical pocket.
- Irrigation fluid additive: During minimally invasive procedures like bladder or kidney surgery, TXA is dissolved at low concentrations (0.2 to 1 mg/mL) into the irrigation fluid that flows through the surgical site continuously.
Some surgeons also mix TXA directly into local anesthetic solutions for skin procedures on the face and head, combining pain control and bleeding reduction in one injection.
Nebulized TXA
For patients coughing up blood (hemoptysis), TXA can be delivered as a mist through a standard nebulizer. This allows the drug to reach the airways directly, where it can act on bleeding surfaces in the lungs. An integrative review of studies published through 2024 found that nebulized TXA achieved rapid cessation of bleeding in most patients, particularly in non-massive cases, and may reduce the need for more invasive procedures like bronchoscopy. Optimal dosing for this route is still being refined.
Dose Adjustments for Kidney Function
TXA is cleared through the kidneys, so reduced kidney function can cause the drug to accumulate. For patients with moderately impaired kidney function (creatinine clearance above 30 mL/min), standard short-duration dosing of up to 2 grams in 24 hours appears safe and effective. Below that threshold, the effects are not well studied, and only a handful of clinical trials have adjusted doses for kidney function at all. If you have known kidney disease, your medical team will likely check your kidney function before deciding on a dose.